Aquestive Therapeutics Statistics
Total Valuation
AQST has a market cap or net worth of $376.02 million. The enterprise value is $442.27 million.
| Market Cap | 376.02M |
| Enterprise Value | 442.27M |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AQST has 89.97 million shares outstanding. The number of shares has increased by 25.69% in one year.
| Shares Outstanding | 89.97M |
| Shares Change (YoY) | +25.69% |
| Shares Change (QoQ) | -6.49% |
| Owned by Insiders (%) | 5.00% |
| Owned by Institutions (%) | 34.18% |
| Float | 65.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.99 |
| Forward PS | 6.92 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.74 |
| EV / EBITDA | 374.17 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24
| Current Ratio | 2.24 |
| Quick Ratio | 1.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | 95.24 |
| Debt / FCF | n/a |
| Interest Coverage | -0.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -13.40% |
| Return on Capital (ROIC) | -248.27% |
| Revenue Per Employee | $374,689 |
| Profits Per Employee | -$58,296 |
| Employee Count | 135 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 3.32 |
Taxes
In the past 12 months, AQST has paid $245,000 in taxes.
| Income Tax | 245,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +207.03% in the last 52 weeks. The beta is 2.91, so AQST's price volatility has been higher than the market average.
| Beta (1Y) | 2.91 |
| 52-Week Price Change | +207.03% |
| 50-Day Moving Average | 4.11 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 45.94 |
| Average Volume (30 Days) | 2,570,745 |
Short Selling Information
The latest short interest is 4.01 million, so 4.46% of the outstanding shares have been sold short.
| Short Interest | 4.01M |
| Short Previous Month | 2.27M |
| Short % of Shares Out | 4.46% |
| Short % of Float | 6.16% |
| Short Ratio (days to cover) | 1.22 |
Income Statement
In the last 12 months, AQST had revenue of $50.58 million and -$7.87 million in losses. Loss per share was -$0.13.
| Revenue | 50.58M |
| Gross Profit | 29.75M |
| Operating Income | -15.10M |
| Pretax Income | -7.63M |
| Net Income | -7.87M |
| EBITDA | 1.18M |
| EBIT | -163,000 |
| Loss Per Share | -$0.13 |
Balance Sheet
The company has $23.87 million in cash and $112.57 million in debt, giving a net cash position of -$88.70 million or -$0.99 per share.
| Cash & Cash Equivalents | 23.87M |
| Total Debt | 112.57M |
| Net Cash | -88.70M |
| Net Cash Per Share | -$0.99 |
| Equity / Book Value | -106.49M |
| Book Value Per Share | -1.18 |
| Working Capital | 22.66M |
Cash Flow
In the last 12 months, operating cash flow was -$6.38 million and capital expenditures -$995,000, giving a free cash flow of -$7.38 million.
| Operating Cash Flow | -6.38M |
| Capital Expenditures | -995,000 |
| Free Cash Flow | -7.38M |
| FCF Per Share | -$0.12 |
Margins
Gross margin is 58.82%, with operating and profit margins of -29.86% and -15.56%.
| Gross Margin | 58.82% |
| Operating Margin | -29.86% |
| Pretax Margin | -15.07% |
| Profit Margin | -15.56% |
| EBITDA Margin | 2.34% |
| EBIT Margin | -0.32% |
| FCF Margin | -14.58% |
Dividends & Yields
AQST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.69% |
| Shareholder Yield | -25.69% |
| Earnings Yield | -2.23% |
| FCF Yield | -2.09% |
Analyst Forecast
The average price target for AQST is $8.83, which is 111.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.83 |
| Price Target Difference | 111.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 23.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AQST has an Altman Z-Score of -5.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.14 |
| Piotroski F-Score | 2 |